Research highlights improved abortion access in Ontario with mifepristone
On April 7th, 2025, a critical research paper was published in the Canadian Medical Association Journal (CMAJ) by authors from the WHRI affiliated Contraception and Abortion Research Team (CART). This study, titled “Changes in local access to mifepristone dispensed by community pharmacies for medication abortion in Ontario: a population-based repeated cross-sectional cohort study.”
The research demonstrates how availability of mifepristone is making abortion more accessible. Specifically, although only 37% of abortion service users lived in an Ontario region with either a mifepristone-dispensing pharmacy or procedural provider in 2017, this increased to 91% by 2022.
The paper’s significance was highlighted by CMAJ by being an Editor’s Pick for the issue.
Media Coverage
The Globe and Mail
Medical Press
CityNews Toronto
Abortion access in Ontario rose to over 90% after the pill was approved: study
Global News
Abortion access in Ontario rose to over 90% after the pill was approved: study